Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Makena Resources Inc
CANSF | US
0.11
USD0
0%
CANSF | US
Loading StockChartView...
About Makena Resources Inc
Sector
Basic Materials
Industry
Industrial Metals & Minerals
Earnings date
30/06/2024
As of date
20/03/2026
Close
0.11
Open
0.11
High
0.11
Low
0.11
Willow Biosciences Inc. a biotechnology company develops produces and sells plant derived ingredients for consumer care food and beverage and pharmaceutical product industries in Canada. Willow Biosciences Inc. is headquartered in Calgary Canada.
View LessCANSF | US
Risk
156.1
Sharpe
0.03
Luna's Score
39/100
Recommendation
Sell
Luna says (CANSF | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
156.1%1 month
156.1%3 months
106.3%6 months
113.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
67.11
Price to book
11.22
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-0.67
Ent. to rev.
8.47
PEG
-
Other Fundamentals
EBITDA
-8.08M
MarketCap
18.17M
MarketCap(USD)
18.17M
Div. yield
-
Op. margin
-140.94
Erngs. growth
-
Rev. growth
660.00
Ret. on equity
-212.20
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.01
Range1M
0.01
Range3M
0.06
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.46
Price X volume
229.60
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.67 | -1.43 | Expensive |
| Ent. to Revenue | 8.47 | 208.44 | Cheaper |
| PE Ratio | - | 47.94 | - |
| Price to Book | 11.22 | 3.33 | Expensive |
| Dividend Yield | - | 2.40 | - |
| Std. Deviation (3M) | 106.26 | 74.41 | Riskier |
| Debt to Equity | - | 0.51 | - |
| Debt to Assets | - | 0.18 | - |
| Market Cap | 18.17M | 9.26B | Emerging |
